SCHEMBL2668093

SCHEMBL2668093

c1cc(-c2ccncc2)c2[nH]nc(Nc3nccs3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 1/20 0.47
▸ PIM1 P11309 2/20 0.39
▸ CSNK2B P67870 2/20 0.39
▸ CSNK2A1 P68400 2/20 0.39
▸ PIM2 Q9P1W9 2/20 0.39
▸ PLA2G7 Q13093 1/20 0.39
▸ MAPK8 P45983 2/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ LTK P29376 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ CSNK1A1 P48729 1/20 0.39
▸ LIMK1 P53667 1/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ ACVR1 Q04771 1/20 0.39
▸ TNK2 Q07912 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660773 0.80 GRM4 (0.51) GRM4PIM1CSNK2BCSNK2A1PIM2
SCHEMBL9072657 0.78 GRM4 (0.38) GRM4PLA2G7MAPK1MEN1KMT2A
SCHEMBL2659927 0.77 ALDH1A1 (0.54) GRM4PLA2G7AURKBSCN9AADRA2A
SCHEMBL2661393 0.71 CSF1R (0.44) CSNK2A1MAPK8MAP4K4CSF1RFGFR1
SCHEMBL2661461 0.70 KDR (0.75) PIM1CSNK2A1MAPK8MAP4K4CSF1R
SCHEMBL31690845 0.70 KDR (0.75) PIM1CSNK2A1MAPK8MAP4K4CSF1R
SCHEMBL2668210 0.69 GRM4 (0.40) GRM4FGFR1KDRMEN1KMT2A
SCHEMBL9072641 0.69 GRM4 (0.40) GRM4PLA2G7AURKBMAPK1MEN1
SCHEMBL9072636 0.68 JAK2 (0.54) GRM4PLA2G7CLK4MAPK1MEN1
SCHEMBL9072655 0.68 GRM4 (0.55) GRM4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110301155-A1 INDAZOLE COMPOUNDS FOR ACTIVATING GLUCOKINASE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-08 — — US disclosed
US-20110301155-A1 INDAZOLE COMPOUNDS FOR ACTIVATING GLUCOKINASE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-08 — — US disclosed
WO-2008156757-A1 INDAZOLE COMPOUNDS FOR ACTIVATING GLUCOKINASE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110301155-A1 INDAZOLE COMPOUNDS FOR ACTIVATING GLUCOKINASE GCKR, GCK, KHK GRM4 2714/4885PIM1 496/4885CSNK2B 353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback